Increasing Number of Acute Kidney Injuries Stokes Continuous Renal Replacement Therapy Market

Continuous renal replacement therapy (CRRT) is a type of treatment utilized for patients suffering from acute kidney injury, wherein they might be admitted in the intensive care units if the cases turn serious. Patients with acute renal failure along with complications such as multiple organ failure and formation of imperfect organs in the renal system might require undergoing continuous renal replacement therapy (CRRT). Cardiac failures including formation of edema, postoperative liver failure, severe acute pancreatitis, fulminant hepatitis, and multiple organ failures are other ailments where continuous renal replacement therapy might be used. Regarding this therapy, the fluid status of the patients is controlled with the help of electrolytic solutions that passes through the patient’s blood. In this way, uremic toxins are removed, the acid-base abnormalities are checked, which gives further information about the patients’ health.

Why is the global continuous renal replacement market being extensively driven in recent times?

Rise in urological disorders, especially those related to kidney failures and urinary incontinency ailments has caused a substantial increase in the demand for continuous renal replacement therapy (CRRT), thereby driving the associated market. Rising geriatric population also has considerably contributed towards the market’s growth in a positive manner, mainly due to a high prevalence of renal problems in old-aged people. Rapid advancements witnessed by the healthcare sector especially in urological studies, coupled with enhanced treatments for getting rise of renal complications also has made patients prefer efficient therapies. Owing to this reason, a high demand for continuous renal replacement has occurred all over the globe in recent time, thus pushing the market.


Which are the chief competitors active in the global continuous renal replacement market?

NxStage Medical, Inc., Fresenius Medical Care AG & Co. KGaA, INFOMED SA, B. Braun Melsungen AG, Baxter International, Inc., Nipro Corporation, Asahi Kasei Medical Co., Ltd., Bellco, Toray Medical Company Limited, and NIKKISO CO., LTD., are major companies operating in the global continuous renal replacement market. The players are focusing on organic as well as inorganic strategies to expand their growth, thereby increasing their customer base to generate more revenue. Looking at the number of competitors present in the market, the vendor landscape appears to be highly fragmented. Moreover, the intensity of competition is expected to increase as new players regularly establish themselves in the market.

What is the nature of the continuous renal replacement therapy market’s geographical outlook?

This market is mainly spread across North America, Europe, the Middle East and Africa, Latin America, and Asia Pacific as its key regional categories. Of these, Europe depicts topmost growth in the market owing to state-of-the-art treatment provided in leading countries situated in this region. However, the forthcoming years forecast Asia Pacific to grow at a strong pace owing to high prevalence of urinary and renal diseases in the region.

0 comments:

Post a Comment

Note: only a member of this blog may post a comment.

Latest Post

Market Research Reports